G. Walter Canonica

TL;DR: These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children and patients are encouraged to use these recommendations in their daily practice and to support their decisions.

TL;DR: This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors, and pathomechanisms, and outlines evidence‐based diagnostic approaches for different subtypes ofUrticaria.

TL;DR: This guideline has a profound impact on the quality of life and effective treatment is, therefore, required and the recommended first line treatment is new generation, nonsedating H1‐antihistamines, and second‐line therapies should be added to the antihistamine treatment.

TL;DR: The Canonica Co-Chairs as discussed by the authors, the first edition of the Canonica International Journal of Distributed Sensoriotemporal Programming (CISDP) conference, were: G. Walter Canonica co-chairs Jean Bousquet, Thomas Casale, Richard F. Lockey, Carlos E. Baena-Cagnani, Ruby Pawankar, Paul C. Ryan, Jan L. Brozek, Enrico Compalati, Ronald Dahl, Luis Delgado, Roy Gerth van Wijk, Richard G. Gower, Dennis K

TL;DR: This paper presents a GA2LEN/EAACI pocket guide for allergen‐specific immunotherapy for allergic rhinitis and asthma and explains the rationale behind the use of this approach.